Sulejman Celaj, MD
Cardiovascular Disease · Bronx, NYNPI 1376717793
Payments from drug & device makers
Across 485 payments — averaging $73.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- Medtronic$8K
- Chiesi USA, Inc.$7K
- Angiodynamics, Inc.$2K
- Novartis$1K
- Novo Nordisk$1K
- plus $9K from 26 others
What the payments were for
- Speaking & faculty fees$13,17537%
- Travel & lodging$2,1526%
- Food & beverage$19,44554%
- Education$2451%
- Other$7662%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 20 | $7,965 |
| Medtronic(2 entities) | 140 | $7,943 |
| Chiesi USA, Inc. | 7 | $6,612 |
| Angiodynamics, Inc. | 2 | $2,465 |
| Novartis | 56 | $1,157 |
| Novo Nordisk | 30 | $1,131 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 48 | $1,014 |
| Johnson & Johnson | 32 | $897 |
| Actelion Pharmaceuticals US, Inc. | 31 | $894 |
| Cardiovascular Systems Inc. | 23 | $777 |
| AstraZeneca | 24 | $771 |
| Welch Allyn | 1 | $766 |
| E.r. Squibb & Sons, L.L.C. | 15 | $494 |
| Abiomed | 7 | $476 |
| Boston Scientific | 5 | $343 |
| Scpharmaceuticals Inc. | 5 | $321 |
| Heartflow, Inc. | 10 | $290 |
| Janssen Scientific Affairs, LLC | 3 | $280 |
| Philips North America LLC | 3 | $196 |
| Biotronik Inc. | 3 | $184 |
| Stryker | 3 | $167 |
| Inari Medical, Inc. | 3 | $160 |
| Biosense Webster, Inc. | 1 | $122 |
| Merck | 3 | $98 |
| Terumo Medical Corporation | 1 | $66 |
| Amgen | 2 | $53 |
| Bristol Myers Squibb | 2 | $41 |
| Boehringer Ingelheim | 1 | $33 |
| Lexicon Pharmaceuticals, Inc. | 1 | $19 |
| Edwards Lifesciences | 1 | $19 |
| Pfizer | 1 | $16 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xience V coronary stent system$6,775
- KENGREAL$5,319
- Resolute$1,434
- JUXTAPID$1,200
- SYMPLICITY G3$1,027
- ONYX FRONTIER$945
- NONE$766
- Xience Sierra Coronary Stent$747
- Coronary Orbital Atherectomy System$612
- CoreValve Evolut$555
- RESOLUTE ONYX$375
- Ozempic$372
- Carto 3$365
- XARELTO$357
- Impella$262
- LifeVest$252
- CAMZYOS$250
- FUROSCIX$250
- Launcher$170
- Telescope$169
How this compares
$35,782 in reported general payments places this provider in the 85th percentile of 2,302 cardiovascular disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ranolazine ErRanolazine | 15 | $451 |
| Metoprolol Succinate | 37 | $381 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 25 | $226 |
| Rosuvastatin Calcium | 18 | $188 |
| Carvedilol | 21 | $112 |
| Atorvastatin Calcium | 27 | $77 |
| Losartan Potassium | 15 | $57 |
| Amlodipine Besylate | 13 | $38 |
| Metoprolol Tartrate | 16 | $29 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Bronx
- Luigi di BiaseBronx$2.5M
- Joseph HelftBronx$488K
- Michele NannaBronx$353K
- James MinNew York$41.1M
- Robert RosensonNew York$6.9M
- Roxana MehranNew York$6.4M
- Roger HajjarNew York$5.2M
- Philippe GenereuxNew York$4.4M
- Vijay IyerAmherst$4.3M
- Gregg StoneNew York$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.